Jul 14, 2023 · Radioembolization is a type of transarterial therapy that strategically attacks liver tumors with localized, high doses of radiation. The treatment often is called Y-90. This refers to the radioactive isotope yttrium-90 that is inserted into tiny glass beads and injected into the tumor's blood supply.

Oct 31, 2019 · Radioembolization with Y90 is a minimally invasive procedure primarily used in the treatment of liver cancer. In contrast to most nuclear medicine applications, Y90 is therapeutic and designed to treat rather than simply diagnose.

Oct 3, 2023 · Y-90 is a targeted way to deliver radiation to a tumor because it radiates less than half an inch into adjacent tissues. This limits the amount of the liver exposed to radiation, and spares normal liver tissue and other nearby organs from unnecessary exposure.

Yttrium-90 (90 Y) is a radioactive isotope of yttrium. [2] Yttrium-90 has found a wide range of uses in radiation therapy to treat some forms of cancer. [3] Along with other isotopes of yttrium, it is sometimes called radioyttrium.

Radioembolization is a minimally invasive procedure that combines embolization and radiation therapy to treat cancers in the liver. Tiny beads filled with a radioactive isotope are placed inside the blood vessels that supply a tumor.

Y90 radioembolization allows doctors to treat the cancer without removing large portions of the liver. Depending on the patient, treating hepatocellular carcinoma with Y90 radioembolization can: help cure the disease. help slow or stop the cancer’s progress and relieve symptoms.

Radioembolization (Y-90) is a minimally invasive treatment for liver cancer that combines embolization and radiation therapy. During Y-90 treatment, tiny glass or resin beads, containing the radioactive isotope yttrium Y-90, are released via a small catheter inside blood vessels that feed the liver tumor(s).

Sep 12, 2023 · Yttrium-90 (Y90) radioembolization, or selective internal radiotherapy, is an alternative treatment option for liver cancer that can’t be cured with typical treatments. The procedure...

Radioembolization (Yttrium-90 embolization or selective internal radiation therapy) Treatment for: Primary or metastatic liver cancer. Why it’s done: All cancers are susceptible to radiation, if high enough doses of radiation can be concentrated in a cancer.

Y-90 SIRT is approved to treat primary liver cancer (HCC) under a special dispensation from the FDA and colorectal cancer that has spread to the liver. In the United States, colorectal cancer is the second leading cause of cancer death.